In a report done by online stock reviews site, Citron Research, the company claimed that Nu Skin was operating its business illegally in China, and was in apparent violation of FDA and FTC regulatory laws in the U.S. Loeb has allegedly been researching the company since 2011.Nu Skin operates in 53 international markets, including America, Asia Pacific, Europe, Africa and the Middle East.